Cipla walk-in on 17th may 2024 freshers and Experience for multiple positions
Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.
Cipla was founded in Mumbai in 1935 by Khwaja Abdul Hamied as the Chemical, Industrial & Pharmaceutical Laboratories. In July 1984, the name of the company was changed to ‘Cipla’. Upon Hamied’s death in 1972, his son Yusuf Hamied, a Cambridge-educated chemist, took over the company. In 1995, Cipla launched Deferiprone, the world’s first oral iron chelator. In 1999, Cipla joined the Indian Pharmaceutical Alliance as a founding member in an effort to promote the development of generic drugs in India. During the AIDS epidemic in the early 2000s, Hamied reverse-engineered a three-drug antiretroviral medication that was sold for about $12,000 per year to create a cheaper version that sold for $304 per year. This drug was sold to African charities and governments. It is estimated that “at one time, as much as 40 percent of the AIDS patients in poor countries took Cipla drugs”. During the avian flu pandemic in 2006, Cipla was able to reverse-engineer the drug Tamiflu and sell it for significantly lower prices. In 2013 Cipla acquired the South African company Cipla-Medpro. Its name was changed to Cipla Medpro South Africa Limited and was kept as a subsidiary. At the time of the acquisition, Cipla-Medpro had been a distribution partner for Cipla and was South Africa’s third-biggest pharmaceutical company. The company had been founded in 2002 under the name Enaleni Pharmaceuticals Ltd. In 2005, Enaleni bought all the shares of Cipla-Medpro, which had been a joint venture between Cipla and Medpro Pharmaceuticals, a South African generics company; in 2008, it changed its name to Cipla-Medpro. In September 2023, it was announced Cipla South Africa had acquired the Midrand-headquartered healthcare products manufacturer, Actor Pharma. In September 2015, Cipla acquired InvaGen Pharmaceuticals and Exelan Pharmaceuticals, two American pharmaceutical companies, for 555 million dollars. In 2019 Cipla entered digital therapeutics by partnering with Wellthy Therapeutics in India and Brandmed in South Africa. In April 2024, Cipla acquired Ivia Beaute Pvt Ltd’s cosmetics and personal care distribution and marketing business for ₹130 crore.
More about company
Vacancy details –
Department – operator production – formulation/ API
Post name- Sr executive/ executive
Experience – 0 to 3 years
Qualification – Diploma, Bsc
Salary – not disclosed by recruiter
Similar job’s
Sun Pharma walk-in on 18th & 19th May 2024
Cipla was founded in Mumbai in 1935 by Khwaja Abdul Hamied as the Chemical, Industrial & Pharmaceutical Laboratories. In July 1984, the name of the company was changed to ‘Cipla’. Upon Hamied’s death in 1972, his son Yusuf Hamied, a Cambridge-educated chemist, took over the company. In 1995, Cipla launched Deferiprone, the world’s first oral iron chelator. In 1999, Cipla joined the Indian Pharmaceutical Alliance as a founding member in an effort to promote the development of generic drugs in India. During the AIDS epidemic in the early 2000s, Hamied reverse-engineered a three-drug antiretroviral medication that was sold for about $12,000 per year to create a cheaper version that sold for $304 per year. This drug was sold to African charities and governments. It is estimated that “at one time, as much as 40 percent of the AIDS patients in poor countries took Cipla drugs”. During the avian flu pandemic in 2006, Cipla was able to reverse-engineer the drug Tamiflu and sell it for significantly lower prices. In 2013 Cipla acquired the South African company Cipla-Medpro. Its name was changed to Cipla Medpro South Africa Limited and was kept as a subsidiary. At the time of the acquisition, Cipla-Medpro had been a distribution partner for Cipla and was South Africa’s third-biggest pharmaceutical company. The company had been founded in 2002 under the name Enaleni Pharmaceuticals Ltd. In 2005, Enaleni bought all the shares of Cipla-Medpro, which had been a joint venture between Cipla and Medpro Pharmaceuticals, a South African generics company; in 2008, it changed its name to Cipla-Medpro. In September 2023, it was announced Cipla South Africa had acquired the Midrand-headquartered healthcare products manufacturer, Actor Pharma. In September 2015, Cipla acquired InvaGen Pharmaceuticals and Exelan Pharmaceuticals, two American pharmaceutical companies, for 555 million dollars.
Important details –
Job location – kurkumbh
Selection process – The selection will be on the basis of interview
Mode of interview – Face to face
Interview rounds of interview – HR
Walk-in interview details –
Date – 17th may 2024
Time – 10:00 Am to 02:00 Pm
Venue – Lemon tree hotel R-7/2 chikalthana airport road, chhatrapati sambhaji Nagar , Maharashtra – 431210
For more job related updates joined WhatsApp group
https://chat.whatsapp.com/KCk1lRtEdlJEJYDBTQNc9i